Cite
HARVARD Citation
Conteduca, V. et al. (2019). Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancer. European journal of cancer. pp. 158-168. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Conteduca, V. et al. (2019). Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancer. European journal of cancer. pp. 158-168. [Online].